|
Jan 20
|
The 2024 Dogs of the Dow: Which Ones Are Buys Right Now?
|
|
Jan 20
|
Retirement Stock Portfolio: 12 Healthcare Stocks To Consider
|
|
Jan 19
|
Here's Why Amgen (AMGN) Gained But Lagged the Market Today
|
|
Jan 19
|
REFILE-UPDATE 2-US FDA adds 'boxed warning' for Amgen's bone loss drug Prolia
|
|
Jan 19
|
Trump and Biden Both Hate Pharma—Investors Shouldn’t
|
|
Jan 17
|
Amgen (AMGN) Ascends While Market Falls: Some Facts to Note
|
|
Jan 15
|
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
|
|
Jan 15
|
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
|
|
Jan 15
|
5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond
|
|
Jan 15
|
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and AstraZeneca
|
|
Jan 12
|
Dow Jones Falls On Cool Inflation Data; Tesla Stock Slides Despite Cathie Wood Buys
|
|
Jan 12
|
FDA Finds No Link Between Obesity Drugs and Suicidal Thoughts
|
|
Jan 11
|
Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights
|
|
Jan 11
|
UPDATE 1-Weight loss drug windfall attracts pharma companies
|
|
Jan 11
|
Xeris (XERS) Up on Licensing Deal With Amgen to Develop Tepezza
|
|
Jan 11
|
Drugmakers plot way into obesity market with deals and development
|
|
Jan 10
|
Dogs of the Dow: January’s Top 3 Picks to Buy for Big Gains
|
|
Jan 10
|
JPM's annual healthcare conference: Here's what's next for GLP-1s and the weight loss market
|
|
Jan 9
|
Dow Jones Futures Fall: Magnificent Seven Stocks Rally; Nvidia Breaks Out Past Buy Point
|
|
Jan 6
|
These Dow Stocks Will Boost Their Dividends Soon
|